Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 2 Comparison of baseline characteristics and frozen-thawed embryo transfer cycle information of three groups after matching

From: Impact of different endometrial preparation protocols on pregnancy outcomes in patients at high risk for ovarian hyperstimulation syndrome: a propensity score matched retrospective cohort study

Characteristics

Matched I

  

Matched II

  

Matched III

  
 

HRT (n = 394)

NC (n = 194)

P value

HRT (n = 272)

OS(n = 136)

P-value

NC (n = 109)

OS (n = 109)

P value

Age of the woman (years, mean ± SD)

30.09 ± 3.30

30.33 ± 3.37

0.411

29.94 ± 2.97

29.92 ± 3.02

0.953

29.85 ± 3.32

29.84 ± 3.09

0.983

Age of the man (years, mean ± SD)

31.74 ± 3.98

31.85 ± 3.54

0.745

31.29 ± 3.53

31.34 ± 3.66

0.907

31.18 ± 3.43

31.33 ± 3.96

0.770

BMI (kg/m 2,mean ± SD)

21.56 ± 2.99

21.45 ± 2.59

0.665

22.50 ± 3.61

22.72 ± 3.29

0.550

22.12 ± 2.80

22.05 ± 2.90

0.856

Regular pattern of menstruation, n(%)

352 (89.34)

179 (90.86)

0.665

171 (62.87)

88 (64.71)

0.799

92 (84.40)

88 (80.73)

0.592

Type of infertility, n(%)

  

0.929

  

0.803

  

0.780

 Primary

159 (40.36)

78 (39.59)

 

111 (40.81)

53 (38.97)

 

43 (39.45)

40 (36.70)

 

 Secondary

235 (59.64)

119 (60.41)

 

161 (59.19)

83 (61.03)

 

66 (60.55)

69 (63.30)

 

Infertility factors, n(%)

  

0.196

  

0.667

  

0.644

 Female factor

223 (56.60)

99 (50.25)

 

175 (64.34)

84 (61.76)

 

54 (49.54)

59 (54.13)

 

 Male factor

95 (24.11)

64 (32.49)

 

45 (16.54)

29 (21.32)

 

33 (30.28)

29 (26.61)

 

 Bilateral factor

38 (9.64)

17 (8.63)

 

32 (11.76)

15 (11.03)

 

10 (9.17)

13 (11.93)

 

 Unexplained

38 (9.64)

17 (8.63)

 

20 (7.35)

8 (5.88)

 

12 (11.01)

8 (7.34)

 

Years of infertility (years, mean ± SD)

3.41 ± 2.18

3.37 ± 2.28

0.834

3.26 ± 2.08

3.35 ± 2.19

0.663

3.05 ± 2.08

3.38 ± 2.31

0.278

Basal FSH(U/L, mean ± SD)

6.52 ± 1.84

6.49 ± 2.09

0.885

6.17 ± 1.78

6.19 ± 1.81

0.929

6.24 ± 2.03

6.20 ± 1.64

0.875

Basal LH (U/L, mean ± SD)

6.59 ± 8.53

6.39 ± 10.17

0.798

5.94 ± 3.47

5.78 ± 4.07

0.685

5.51 ± 4.91

5.44 ± 3.98

0.913

AFC (n, mean ± SD)

16.90 ± 6.42

16.43 ± 4.88

0.364

19.00 ± 7.10

18.43 ± 6.33

0.435

16.81 ± 4.88

17.09 ± 6.03

0.702

Protocol in fresh cycle, n(%)

  

0.736

  

0.292

  

0.594

 Follicular-phase depot GnRH agonist

127 (32.23)

59 (29.95)

 

118 (43.38)

52 (38.24)

 

33 (30.28)

36 (33.03)

 

 Mid-luteal GnRH agonist

159 (40.36)

86 (43.65)

 

70 (25.74)

45 (33.09)

 

38 (34.86)

42 (38.53)

 

 Antagonist

108 (27.41)

52 (26.40)

 

84 (30.88)

39 (28.68)

 

38 (34.86)

31 (28.44)

 

Fertilization type, n(%)

  

1.000

  

1.000

  

0.874

 IVF

321 (81.47)

161 (81.73)

 

222 (81.62)

111 (81.62)

 

82 (75.23)

84 (77.06)

 

 ICSI

73 (18.53)

36 (18.27)

 

50 (18.38)

25 (18.38)

 

27 (24.77)

25 (22.94)

 

Gn time of use (d, mean ± SD)

10.38 ± 2.01

10.30 ± 1.96

0.683

10.61 ± 2.12

10.54 ± 2.15

0.755

10.41 ± 2.06

10.27 ± 1.68

0.565

Gn dosage (U, mean ± SD)

1858.66 ± 673.85

1863.97 ± 665.70

0.928

1946.19 ± 750.44

1941.27 ± 827.32

0.952

1950.94 ± 699.34

1900.11 ± 731.45

0.601

Trigger day E2 value (ng/L, mean ± SD)

5934.80 ± 2390.08

5986.06 ± 2572.71

0.811

5499.41 ± 2382.22

5436.10 ± 2656.40

0.808

5660.43 ± 2497.75

5514.87 ± 2668.19

0.678

No. of oocyte retrieved(n, mean ± SD)

19.64 ± 6.14

19.50 ± 5.86

0.792

20.08 ± 6.36

20.10 ± 6.45

0.974

19.39 ± 5.64

19.88 ± 5.85

0.533

  1. Note: HRT: hormone replacement therapy; NC: natural cycle; OS: ovarian stimulation; Matched I: The HRT and NC groups were matched at a 2:1 ratio using a propensity score matching tolerance of 0.02. Matched II: The HRT and OS groups were matched at a 2:1 ratio using a propensity score matching tolerance of 0.02. Matched III: The NC and OS groups were matched at a
  2. 1:1 ratio using a propensity score matching tolerance of 0.02.SD: standard deviation; BMI: body mass index; FSH: follicle stimulating hormone; LH: luteinizing hormone; AFC: antral follicle count; IVF: in vitro fertilization; ICSI: intracytoplasmic sperm injection; Gn: gonadotropin; E2:estradiol;